Importantly, we have also uncovered correlations between RBMS2 expression and immune infiltration in ccRCC, suggesting a potential role of RBMS2 in modulating the tumor immune microenvironment. The gene discussed is RBMS2; the disease is nonpapillary renal cell carcinoma.